Oral Cancer: Page 21

Study: Data suggest novel approach to treat early-stage oral cancer

By Tony Edwards

Of the many ongoing issues around oral cancer treatment is a lack of "significant improvement" in disease prognosis over the last several decades. Now a study in JAMA Otolaryngology -- Head and Neck Surgery presents, for the first time, outcome data for almost 250 patients using a novel optical approach at the point of care to treat early-stage oral cancer.

January 19, 2016

FDA fast-tracks Galera's oral mucositis therapy

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) has granted fast-track status to Galera Therapeutics for a drug that may reduce the severity and incidence of radiation- and chemotherapy-induced oral mucositis.

January 11, 2016

FDA OKs nonalcohol docetaxel for head/neck cancer

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) has approved Teikoku Pharma USA's nonalcohol docetaxel injection for the treatment of head and neck cancer, breast cancer, non-small cell lung cancer, prostate cancer, and gastric adenocarcinoma.

December 28, 2015

Study: PET/CT aids radiation treatment in HNC patients

By Donna Domino

The use of PET/CT can improve radiation treatment planning for patients with head and neck cancers (HNCs), according to a review of studies that was recently published in the World Journal of Radiology.

December 28, 2015

Forward Science donates 5th OralID

By DrBicuspid.com staff writers

Forward Science Technologies, the developer of the OralID cancer screening device, has donated a fifth device as part of its OralID Facebook Charity Campaign.

December 21, 2015

Bavarian Nordic partners with Janssen for HPV vaccine

By DrBicuspid.com staff writers

Bavarian Nordic has entered into a license and collaboration agreement with Janssen Pharmaceuticals to target HPV-related cancers.

December 20, 2015

DrBicuspid.com Dental Excellence Awards 2015 finalists

By Tony Edwards

DrBicuspid.com is pleased to announce the finalists chosen by our readers in the 2015 Dental Excellence Awards. We want to thank the hundreds of readers who participated in the voting.

December 16, 2015

Forward Science, OCF partner to share patient story

By DrBicuspid.com staff writers

To spread awareness about the importance of annual oral cancer screenings, Forward Science Technologies and the Oral Cancer Foundation (OCF) have partnered to share the story of a family's loss after a protracted and difficult battle with oral cancer.

December 7, 2015

GNYDM 2015 Preview: Oral cancer experts to be featured

By Donna Domino

A panel of experts will discuss the current surgical and medical management of oral cancer patients at the upcoming Greater New York Dental Meeting (GNYDM). Experts in otolaryngology, pathology, craniofacial surgery, oncology, and maxillofacial prosthetics will present diagnostic criteria, rehabilitative care, and guidelines for oral cancer.

November 26, 2015

FDA fast-tracks Cellceutix's oral mucositis therapy

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) has granted fast-track status to biopharmaceutical company Cellceutix for Brilacidin-OM, a mouth rinse to prevent oral mucositis.

November 24, 2015

DrBicuspid.com Oral Cancer & Diagnostics Insider: Experts featured at GNYDM

By Donna Domino

November 18, 2015

Study: HNC patients have increased suicide risk

By Tony Edwards

The suicide rate of patients with head and neck cancer (HNC) is more than three times the rate of the U.S. general population, according to a new study in JAMA Otolaryngology -- Head and Neck Cancer.

November 18, 2015

Previous Page

Page 21 of 116

Next Page